Alpine Associates Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Alpine Associates Management’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,215,566	Closed	-$66.9M	–	88
2016 Q2	$66.9M	Buy	+2,215,566	New	+$45M	2.39%	16

Alpine Associates Management's CPXX Position: Q3 2016 in Review

Alpine Associates Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 2,215,566 shares — an estimated $66.9M sold.

Alpine Associates Management first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $66.9M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Alpine Associates Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Alpine Associates Management sold 2,215,566 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $66.9M.
Alpine Associates Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Alpine Associates Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $66.9M in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Alpine Associates Management's 13F filing for Q3 2016, filed 10 Nov 2016.